Author:
Abe Masatoshi,Abe Fuminori,Nishimura Chihiro,Ichimura Eiji,Ogasawara Asuka,Ichinei Megumi,Muraoka Yasuhiko,Saino Tetsushi
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference24 articles.
1. Meester ID, Korom S, Damme JV, Scharpe S . CD26, let it cut or cut it down. Immunol Today 20: 367–375 ( 1999)
2. Augustyns K, Bal G, Thonus G, Belyaev A, Zhang XM, Bollaert W, Lambeir AM, Durinx C, Goosens F, Haemers A . The unique properties of dipeptidyl-peptidase IV (DPPIV) and the therapeutic potential of DPPIV inhibitors. Current Medical Chem. 6: 311–327 ( 1999)
3. Christopherson K, Hangoc WG, Mantel CR, Broxmeyer HE . Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305: 1000–1003 ( 2004)
4. Cheng JD, Dunbrack RL, Valianou JM, Rogatko A, Alpaugh K, Weiner LM . Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62: 67–72 ( 2002)
5. Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, Prasad K, Mangold BL, Russell ME, Hughes TE . 1-[[(3-Hydroxy-1-adamantyl)amino] acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J. Med. Chem. 46: 2774–2789 ( 2003)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献